Literature DB >> 25192603

Magnetic resonance imaging and clinical assessments for perianal Crohn's disease: gain and limits.

Aurélien Garros1, Laurent Siproudhis2, Belinda Tchoundjeu1, Tanguy Rohou3, Charlène Brochard1, Timothée Wallenhorst1, Jean-François Bretagne1, Guillaume Bouguen4.   

Abstract

BACKGROUND: Assessment of perianal Crohn's disease remains challenging. European Crohn's and Colitis Organisation (ECCO) recommend magnetic resonance imaging (MRI) as a gold standard, but both accuracy and advantages remain limited compared to systematic clinical assessment. The aim of this study was to define their actual diagnostic value.
METHODS: We performed a retrospective analysis of a prospective database of consecutive patients with perianal Crohn's disease assessed by magnetic resonance imaging and clinical examination from 2006 to 2012. At each outpatient visit, perianal activity (Perianal Disease Activity Index) and perianal phenotype (Cardiff-Hughes classification) were noted. MRI was interpreted according to Cardiff-Hughes and Van Assche classifications.
RESULTS: Overall, 122 combined evaluations were assessed in 70 patients. Radiological imaging failed to show superficial ulcerations in 20/21 patients (95%) and severe ulcerations in 13/15 patients (87%). It consistently failed to diagnose anal stenosis (n=21, 100%). For fistulising lesions, the global agreement between the two methods was 71/122 (58%) in assessing complex fistulas. Clinical assessment underestimated 44/68 (65%) of multiple or ramified fistula tracts. Clinical examination failed to diagnose half of the radiological abscesses.
CONCLUSIONS: Current ECCO guidelines should be applied with some caution because of the low sensitivity of MRI for the diagnosis of non-fistulising perianal disease. Combining clinical and MRI assessments improves diagnostic accuracy.
Copyright © 2014 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Diagnostic accuracy; Pelvic magnetic resonance imaging; Perianal Crohn's disease; Perianal examination; Sensitivity

Mesh:

Year:  2014        PMID: 25192603     DOI: 10.1016/j.dld.2014.08.003

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  4 in total

Review 1.  British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.

Authors:  Christopher Andrew Lamb; Nicholas A Kennedy; Tim Raine; Philip Anthony Hendy; Philip J Smith; Jimmy K Limdi; Bu'Hussain Hayee; Miranda C E Lomer; Gareth C Parkes; Christian Selinger; Kevin J Barrett; R Justin Davies; Cathy Bennett; Stuart Gittens; Malcolm G Dunlop; Omar Faiz; Aileen Fraser; Vikki Garrick; Paul D Johnston; Miles Parkes; Jeremy Sanderson; Helen Terry; Daniel R Gaya; Tariq H Iqbal; Stuart A Taylor; Melissa Smith; Matthew Brookes; Richard Hansen; A Barney Hawthorne
Journal:  Gut       Date:  2019-09-27       Impact factor: 23.059

2.  Guidelines for the management of patients with Crohn's disease. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology.

Authors:  Michał Łodyga; Piotr Eder; Magdalena Gawron-Kiszka; Agnieszka Dobrowolska; Maciej Gonciarz; Marek Hartleb; Maria Kłopocka; Ewa Małecka-Wojciesko; Piotr Radwan; Jarosław Reguła; Edyta Zagórowicz; Grażyna Rydzewska
Journal:  Prz Gastroenterol       Date:  2021-11-19

3.  MR imaging of perianal fistulas in Crohn's disease: sensitivity and specificity of STIR sequences.

Authors:  Giuseppe Lo Re; Chiara Tudisca; Federica Vernuccio; Dario Picone; Maria Cappello; Francesco Agnello; Massimo Galia; Maria Cristina Galfano; Ennio Biscaldi; Sergio Salerno; Antonio Pinto; Massimo Midiri; Roberto Lagalla
Journal:  Radiol Med       Date:  2015-12-07       Impact factor: 3.469

4.  Infliximab for Crohn's Disease Patients with Perianal Fistulas: Better Image, Better Life.

Authors:  Liwen Hong; Chen Zhang; Rong Fan; Lei Wang; Zhengting Wang; Tianyu Zhang; Jie Zhong
Journal:  Med Sci Monit       Date:  2020-08-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.